A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
Kivu Bioscience Inc.
Hoffmann-La Roche
Bayer
ViroMissile, Inc.
Karyopharm Therapeutics Inc
AstraZeneca
MacroGenics
Avacta Life Sciences Ltd
Solve Therapeutics
Adela, Inc
Perspective Therapeutics
Ocellaris Pharma, Inc.
Tanabe Pharma America, Inc.
HiFiBiO Therapeutics
TScan Therapeutics, Inc.
Actym Therapeutics, Inc.
AVM Biotechnology Inc
Telix Pharmaceuticals (Innovations) Pty Limited
PharmaMar
Elevation Oncology
Labcorp Corporation of America Holdings, Inc
Cybrexa Therapeutics
Agenus Inc.
Medigene AG
Cyteir Therapeutics, Inc.
Shanghai PerHum Therapeutics Co., Ltd.
NantCell, Inc.
Xencor, Inc.
Prelude Therapeutics
Innolake Biopharm
Pfizer
Celon Pharma SA
Adaptimmune
Corvus Pharmaceuticals, Inc.
Sumitomo Pharma America, Inc.
pharmaand GmbH
Kineta Inc.
Shanghai Yunying Medical Technology
Prelude Therapeutics
Quadriga Biosciences, Inc.
MacroGenics
Hebei Senlang Biotechnology Inc., Ltd.
NKGen Biotech, Inc.
SpeciCare
Seagen Inc.
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Celgene
Tocagen Inc.
Merrimack Pharmaceuticals
Corcept Therapeutics